Status:
COMPLETED
Telestroke at Comprehensive Stroke Center During the COVID-19 Pandemic
Lead Sponsor:
University of Minnesota
Conditions:
Stroke, Acute
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
TELEstroke to CAre for STroke Patients at a Comprehensive Stroke Center (TELECAST-CSC) during the COVID-19 pandemic is a pre-post study evaluating guideline-based acute ischemic stroke care following ...
Detailed Description
The SARS-Cov-2 virus originated in Wuhan China in 2019 and rapidly became a global pandemic. Beyond the pandemic, stroke care is further impacted directly by COVID-19-induced systemic inflammatory res...
Eligibility Criteria
Inclusion
- Age 18 and above
- Patients with the primary diagnosis of ischemic stroke admitted to Fairview Southdale Hospitals
- Evidence of stroke on MRI or CT or clinical diagnosis of acute ischemic stroke by the treating stroke service.
Exclusion
- Patients less than 18 years old
- Patients who leave the hospital against medical advice
- Patients with goals of care that impact the stroke evaluation (i.e. comfort measures)
- Patients who have an alternative diagnosis
- Patients who opt out of the study
Key Trial Info
Start Date :
December 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 29 2020
Estimated Enrollment :
296 Patients enrolled
Trial Details
Trial ID
NCT04761874
Start Date
December 1 2019
End Date
September 29 2020
Last Update
April 22 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
M Health Fairview Southdale Hospital
Edina, Minnesota, United States, 55435